SK14122000A3 - Substituované benzamidy, ich príprava a použitie - Google Patents
Substituované benzamidy, ich príprava a použitie Download PDFInfo
- Publication number
- SK14122000A3 SK14122000A3 SK1412-2000A SK14122000A SK14122000A3 SK 14122000 A3 SK14122000 A3 SK 14122000A3 SK 14122000 A SK14122000 A SK 14122000A SK 14122000 A3 SK14122000 A3 SK 14122000A3
- Authority
- SK
- Slovakia
- Prior art keywords
- phenyl
- alkyl
- benzamide
- branched
- unbranched
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/64—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings
- C07C233/77—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups
- C07C233/78—Carboxylic acid amides having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by amino groups with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
- C07C237/28—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton
- C07C237/34—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atom of at least one of the carboxamide groups bound to a carbon atom of a non-condensed six-membered aromatic ring of the carbon skeleton having the nitrogen atom of the carboxamide group bound to an acyclic carbon atom of a hydrocarbon radical substituted by nitrogen atoms not being part of nitro or nitroso groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/15—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings
- C07C311/21—Sulfonamides having sulfur atoms of sulfonamide groups bound to carbon atoms of six-membered aromatic rings having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D213/56—Amides
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Cardiology (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Pain & Pain Management (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Vascular Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Oncology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19817461A DE19817461A1 (de) | 1998-04-20 | 1998-04-20 | Neue substituierte Benzamide, deren Herstellung und Anwendung |
PCT/EP1999/002617 WO1999054293A1 (de) | 1998-04-20 | 1999-04-19 | Substituierte benzamide, deren herstellung und anwendung als inhibitoren von cystein-proteasen |
Publications (1)
Publication Number | Publication Date |
---|---|
SK14122000A3 true SK14122000A3 (sk) | 2001-05-10 |
Family
ID=7865113
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1412-2000A SK14122000A3 (sk) | 1998-04-20 | 1999-04-19 | Substituované benzamidy, ich príprava a použitie |
Country Status (21)
Country | Link |
---|---|
US (1) | US6436925B1 (de) |
EP (1) | EP1073632A1 (de) |
JP (1) | JP2002512220A (de) |
KR (1) | KR20010042837A (de) |
CN (1) | CN1306509A (de) |
AU (1) | AU743245B2 (de) |
BG (1) | BG104856A (de) |
BR (1) | BR9909776A (de) |
CA (1) | CA2328430A1 (de) |
CZ (1) | CZ20003890A3 (de) |
DE (1) | DE19817461A1 (de) |
HR (1) | HRP20000777A2 (de) |
HU (1) | HUP0101616A3 (de) |
ID (1) | ID26305A (de) |
IL (1) | IL138676A0 (de) |
NO (1) | NO20005265L (de) |
PL (1) | PL343466A1 (de) |
SK (1) | SK14122000A3 (de) |
TR (1) | TR200003069T2 (de) |
WO (1) | WO1999054293A1 (de) |
ZA (1) | ZA200006758B (de) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020013942A (ko) * | 1999-07-01 | 2002-02-21 | 우에하라 아끼라 | 아미노벤조산 유도체 |
US6846813B2 (en) * | 2000-06-30 | 2005-01-25 | Pharmacia & Upjohn Company | Compounds to treat alzheimer's disease |
PE20020506A1 (es) * | 2000-08-22 | 2002-07-09 | Glaxo Group Ltd | Derivados de pirazol fusionados como inhibidores de la proteina cinasa |
DE10114762A1 (de) * | 2001-03-26 | 2002-10-02 | Knoll Gmbh | Verwendung von Cysteinprotease-Inhibitoren |
WO2003013518A1 (en) * | 2001-08-03 | 2003-02-20 | Smithkline Beecham Corporation | Alpha-ketoamide derivatives as cathepsin k inhibitors |
GB0124939D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124938D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124932D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124936D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124931D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124933D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124941D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
GB0124934D0 (en) * | 2001-10-17 | 2001-12-05 | Glaxo Group Ltd | Chemical compounds |
EP1465862A1 (de) | 2002-01-17 | 2004-10-13 | SmithKline Beecham Corporation | Cycloalkyl-ketoamiden derivate und ihre verwendung als cathepsin-k-inhibitoren |
NZ533865A (en) * | 2002-02-12 | 2006-02-24 | Smithkline Beecham Corp | Nicotinamide derivates useful as p38 inhibitors |
GB0217757D0 (en) | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Novel compounds |
CA2505098A1 (en) | 2002-11-12 | 2004-05-27 | Merck & Co., Inc. | Phenylcarboxamide beta-secretase inhibitors for the treatment of alzheimer's disease |
GB0228410D0 (en) | 2002-12-05 | 2003-01-08 | Glaxo Group Ltd | Novel Compounds |
GB0308201D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308186D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0308185D0 (en) * | 2003-04-09 | 2003-05-14 | Smithkline Beecham Corp | Novel compounds |
GB0318814D0 (en) * | 2003-08-11 | 2003-09-10 | Smithkline Beecham Corp | Novel compounds |
RU2390520C2 (ru) * | 2003-12-22 | 2010-05-27 | Адзиномото Ко., Инк. | Новые производные фенилаланина |
GB0402143D0 (en) * | 2004-01-30 | 2004-03-03 | Smithkline Beecham Corp | Novel compounds |
US20080051416A1 (en) * | 2004-10-05 | 2008-02-28 | Smithkline Beecham Corporation | Novel Compounds |
GB0512429D0 (en) * | 2005-06-17 | 2005-07-27 | Smithkline Beecham Corp | Novel compound |
ES2381879T3 (es) | 2006-12-29 | 2012-06-01 | Abbott Gmbh & Co. Kg | Compuestos de carboxamida y su uso como inhibidores de calpaína |
TWI453019B (zh) | 2007-12-28 | 2014-09-21 | Abbvie Deutschland | 甲醯胺化合物 |
AR077525A1 (es) * | 2009-01-30 | 2011-09-07 | Novartis Ag | 4-aril-butan-1,3-diamidas y composiciones farmaceuticas |
TWI519530B (zh) | 2009-02-20 | 2016-02-01 | 艾伯維德國有限及兩合公司 | 羰醯胺化合物及其作為鈣蛋白酶(calpain)抑制劑之用途 |
WO2013149800A1 (en) | 2012-04-03 | 2013-10-10 | AbbVie Deutschland GmbH & Co. KG | Carboxamide compounds and their use as calpain inhibitors v |
CN106536520B (zh) | 2014-06-27 | 2020-08-14 | 诺格拉制药有限公司 | 芳基受体调制剂及其制备和使用方法 |
US10590084B2 (en) | 2016-03-09 | 2020-03-17 | Blade Therapeutics, Inc. | Cyclic keto-amide compounds as calpain modulators and methods of production and use thereof |
EP3481835A4 (de) | 2016-07-05 | 2020-02-26 | Blade Therapeutics, Inc. | Calpain-modulatoren und therapeutische verwendungen davon |
EP3523294A4 (de) | 2016-09-28 | 2021-01-13 | Blade Therapeutics, Inc. | Calpain-modulatoren und therapeutische verwendungen davon |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ305626A (en) | 1995-03-24 | 2000-01-28 | Axys Pharm Inc | Reversible protease inhibitors |
JP2000517319A (ja) * | 1996-08-28 | 2000-12-26 | スミスクライン・ビーチャム・コーポレイション | システインプロテアーゼのインヒビター |
WO1998025883A1 (de) | 1996-12-11 | 1998-06-18 | Basf Aktiengesellschaft | Ketobenzamide als calpain-inhibitoren |
-
1998
- 1998-04-20 DE DE19817461A patent/DE19817461A1/de not_active Withdrawn
-
1999
- 1999-04-19 SK SK1412-2000A patent/SK14122000A3/sk unknown
- 1999-04-19 WO PCT/EP1999/002617 patent/WO1999054293A1/de not_active Application Discontinuation
- 1999-04-19 JP JP2000544634A patent/JP2002512220A/ja active Pending
- 1999-04-19 PL PL99343466A patent/PL343466A1/xx not_active Application Discontinuation
- 1999-04-19 EP EP99920704A patent/EP1073632A1/de not_active Withdrawn
- 1999-04-19 HU HU0101616A patent/HUP0101616A3/hu unknown
- 1999-04-19 CZ CZ20003890A patent/CZ20003890A3/cs unknown
- 1999-04-19 CN CN99807638A patent/CN1306509A/zh active Pending
- 1999-04-19 US US09/647,673 patent/US6436925B1/en not_active Expired - Fee Related
- 1999-04-19 KR KR1020007011601A patent/KR20010042837A/ko not_active Application Discontinuation
- 1999-04-19 CA CA002328430A patent/CA2328430A1/en not_active Abandoned
- 1999-04-19 BR BR9909776-1A patent/BR9909776A/pt not_active IP Right Cessation
- 1999-04-19 AU AU38186/99A patent/AU743245B2/en not_active Ceased
- 1999-04-19 ID IDW20002113A patent/ID26305A/id unknown
- 1999-04-19 TR TR2000/03069T patent/TR200003069T2/xx unknown
- 1999-04-19 IL IL13867699A patent/IL138676A0/xx unknown
-
2000
- 2000-10-13 BG BG104856A patent/BG104856A/xx unknown
- 2000-10-19 NO NO20005265A patent/NO20005265L/no not_active Application Discontinuation
- 2000-11-15 HR HR20000777A patent/HRP20000777A2/hr not_active Application Discontinuation
- 2000-11-20 ZA ZA200006758A patent/ZA200006758B/en unknown
Also Published As
Publication number | Publication date |
---|---|
AU743245B2 (en) | 2002-01-24 |
HUP0101616A1 (hu) | 2001-09-28 |
AU3818699A (en) | 1999-11-08 |
DE19817461A1 (de) | 1999-10-21 |
WO1999054293A1 (de) | 1999-10-28 |
PL343466A1 (en) | 2001-08-13 |
EP1073632A1 (de) | 2001-02-07 |
ID26305A (id) | 2000-12-14 |
BG104856A (en) | 2001-05-31 |
CA2328430A1 (en) | 1999-10-28 |
HUP0101616A3 (en) | 2002-10-28 |
NO20005265D0 (no) | 2000-10-19 |
KR20010042837A (ko) | 2001-05-25 |
TR200003069T2 (tr) | 2009-01-21 |
ZA200006758B (en) | 2001-12-12 |
CZ20003890A3 (cs) | 2001-11-14 |
CN1306509A (zh) | 2001-08-01 |
BR9909776A (pt) | 2000-12-19 |
JP2002512220A (ja) | 2002-04-23 |
NO20005265L (no) | 2000-10-19 |
HRP20000777A2 (en) | 2001-06-30 |
IL138676A0 (en) | 2001-10-31 |
US6436925B1 (en) | 2002-08-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SK14122000A3 (sk) | Substituované benzamidy, ich príprava a použitie | |
AU721620B2 (en) | Novel ketobenzamides and their use | |
US7956093B2 (en) | Substituted amides, their preparation and use | |
US6562827B1 (en) | Heterocyclically substituted amides used as calpain inhibitors | |
US6448254B1 (en) | Substituted amides, their production and their use | |
JP4621350B2 (ja) | 複素環置換アミド、その製造および使用 | |
US6380220B1 (en) | Derivatives from piperidine-keto acid, their preparation and use | |
JP2011063604A (ja) | 新規の複素環式の置換されたアミド、その製造および使用 | |
SK56599A3 (en) | Benzamidoaldehydes and their use | |
SK56699A3 (en) | Novel heterocyclically substituted benzamides and their use | |
SK15062000A3 (sk) | Amidy s heterocyklickými substituentmi, ich príprava a použitie | |
MXPA00010149A (en) | Substituted benzamides, their production and their use as cysteine protease inhibitors | |
MXPA00009969A (en) | New substituted amides, their production and their use | |
CZ208499A3 (cs) | Ketobenzamidy a jejich použití |